Atrial fibrillation: real-life experience of a rhythm control with electrical cardioversion in a community hospital
- PMID: 38632510
- PMCID: PMC11022487
- DOI: 10.1186/s12872-024-03885-0
Atrial fibrillation: real-life experience of a rhythm control with electrical cardioversion in a community hospital
Abstract
Background: Atrial fibrillation is the most prevalent sustained cardiac arrhythmia. Electrical cardioversion, a well-established part of the rhythm control strategy, is probably underused in community settings. Here, we describe its use, safety, and effectiveness in a cohort of patients with atrial fibrillation treated in rural settings.
Methods: It is a retrospective cohort study. Data on all procedures from January 1, 2016, till December 1, 2022, in Tarusa Hospital, serving mostly a rural population of 15,000 people, were extracted from electronic health records. Data on the procedure's success, age, gender, body mass index, comorbidities, previous procedures, echocardiographic parameters, type and duration of arrhythmia, anticoagulation, antiarrhythmic drugs, transesophageal echocardiography, and settings were available.
Results: Altogether, 1,272 procedures in 435 patients were performed during the study period. The overall effectiveness of the procedure was 92%. Effectiveness was similar across all prespecified subgroups. Electrical cardioversion was less effective in patients undergoing the procedure for the first time (86%, 95% CI: 82-90) compared to repeated procedures (95%, 95% CI: 93-96), OR 0.39 (95% CI: 0.26-0.59). Complications were encountered in 13 (1.02%) procedures but were not serious.
Conclusions: Electrical cardioversion is an immediately effective procedure that can be safely performed in community hospitals, both in inpatient and outpatient settings. Further studies with longer follow-up are needed to investigate the rate of sinus rhythm maintenance in these patients.
Keywords: Atrial fibrillation; Community hospital; Electrical cardioversion.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Is left atrial appendage flow a predictor for outcome of cardioversion of nonvalvular atrial fibrillation? A transthroacic and transesophageal echocardiographic study.Am Heart J. 1997 Oct;134(4):745-51. doi: 10.1016/s0002-8703(97)70059-0. Am Heart J. 1997. PMID: 9351743
-
Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation.Int J Cardiol. 2003 Apr;88(2-3):157-66. doi: 10.1016/s0167-5273(02)00380-7. Int J Cardiol. 2003. PMID: 12714194 Clinical Trial.
-
[Anticoagulation and electrical cardioversion of chronic atrial fibrillation: proposal for an abbreviated protocol].G Ital Cardiol. 1997 Aug;27(8):803-10. G Ital Cardiol. 1997. PMID: 9312508 Italian.
-
Cardioversion in Non-Valvular Atrial Fibrillation.Dtsch Arztebl Int. 2015 Dec 11;112(50):856-62. doi: 10.3238/arztebl.2015.0856. Dtsch Arztebl Int. 2015. PMID: 26763380 Free PMC article. Review.
-
[Electrical and pharmacological strategies for early cardioversion of atrial fibrillation].Herzschrittmacherther Elektrophysiol. 2006 Jun;17(2):81-8. doi: 10.1007/s00399-006-0514-0. Herzschrittmacherther Elektrophysiol. 2006. PMID: 16786466 Review. German.
References
-
- Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2021;42(5):373–498. doi: 10.1093/eurheartj/ehaa612. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical